127 related articles for article (PubMed ID: 36461317)
1. Walnut peptide loaded proliposomes with hydroxyapatite as a carrier: Fabrication, environmental stability, and in vitro digestion attribute.
Luo Y; Wang F; Yuan X; Wang K; Sun Q; Wang H; Pu C; Tang W
Food Res Int; 2022 Dec; 162(Pt B):112057. PubMed ID: 36461317
[TBL] [Abstract][Full Text] [Related]
2. Fabrication and characterization of walnut peptides-loaded proliposomes with three lyoprotectants: Environmental stabilities and antioxidant/antibacterial activities.
Wang F; Pu C; Liu M; Li R; Sun Y; Tang W; Sun Q; Tian Q
Food Chem; 2022 Jan; 366():130643. PubMed ID: 34330031
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and stability of nanoliposomes loaded with peptides from defatted walnut (
Zhang G; Fang S; Regenstein JM; Wang F
J Food Sci Technol; 2022 Aug; 59(8):3180-3191. PubMed ID: 35872726
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method.
Karn PR; Jin SE; Lee BJ; Sun BK; Kim MS; Sung JH; Hwang SJ
Int J Nanomedicine; 2014; 9():5079-91. PubMed ID: 25395846
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
Arregui JR; Kovvasu SP; Betageri GV
AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
[TBL] [Abstract][Full Text] [Related]
6. Future drug delivery research in South Korea.
Chung SJ
J Control Release; 1999 Nov; 62(1-2):73-9. PubMed ID: 10518638
[TBL] [Abstract][Full Text] [Related]
7. The preparation of Cistanche phenylethanoid glycosides liquid proliposomes: Optimized formulation, characterization and proliposome dripping pills in vitro and in vivo evaluation.
Li M; Li Y; Liu W; Li R; Qin C; Liu N; Han J
Eur J Pharm Sci; 2016 Oct; 93():224-32. PubMed ID: 27493021
[TBL] [Abstract][Full Text] [Related]
8. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
Gomez AI; Acosta MF; Muralidharan P; Yuan JX; Black SM; Hayes D; Mansour HM
Pulm Pharmacol Ther; 2020 Oct; 64():101975. PubMed ID: 33137515
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid proliposomes mediated by mannosylated ligand: Preparation, physicochemical characterization, environmental stability and bioactivity evaluation.
Chen J; Lin Y; Wu M; Li C; Cen K; Liu F; Liao Y; Zhou X; Xu J; Cheng Y
Colloids Surf B Biointerfaces; 2022 Oct; 218():112781. PubMed ID: 36007313
[TBL] [Abstract][Full Text] [Related]
10. A drift on liposomes to proliposomes: recent advances and promising approaches.
Dhiman N; Sarvaiya J; Mohindroo P
J Liposome Res; 2022 Dec; 32(4):317-331. PubMed ID: 35037565
[TBL] [Abstract][Full Text] [Related]
11. Carboxymethyl chitosan-decorated proliposomes as carriers for improved stability and sustained release of flaxseed oil.
Song FF; Tian SJ; Chen FS; Sun XY; Zhang BB
J Food Sci; 2020 Oct; 85(10):3237-3243. PubMed ID: 32860245
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-coated nanoliposomes for the enhanced stability of walnut angiotensin-converting enzyme (ACE) inhibitory peptide.
Cao S; Hao J; Wang Y; Zhou X; Wang F
J Food Sci; 2023 May; 88(5):2130-2140. PubMed ID: 37039471
[TBL] [Abstract][Full Text] [Related]
13. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.
Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS
Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439
[TBL] [Abstract][Full Text] [Related]
14. Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo.
Chu C; Tong SS; Xu Y; Wang L; Fu M; Ge YR; Yu JN; Xu XM
Acta Pharmacol Sin; 2011 Jul; 32(7):973-80. PubMed ID: 21666703
[TBL] [Abstract][Full Text] [Related]
15. Study on an injectable biomedical paste using cross-linked sodium hyaluronate as a carrier of hydroxyapatite particles.
Liu Y; Wu Y; Lin H; Xiao Y; Zhu X; Zhang K; Fan Y; Zhang X
Carbohydr Polym; 2018 Sep; 195():378-386. PubMed ID: 29804989
[TBL] [Abstract][Full Text] [Related]
16. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
Hiremath PS; Soppimath KS; Betageri GV
Int J Pharm; 2009 Oct; 380(1-2):96-104. PubMed ID: 19616608
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyapatite nanorod and microsphere functionalized with bioactive lactoferrin as a new biomaterial for enhancement bone regeneration.
Shi P; Wang Q; Yu C; Fan F; Liu M; Tu M; Lu W; Du M
Colloids Surf B Biointerfaces; 2017 Jul; 155():477-486. PubMed ID: 28472751
[TBL] [Abstract][Full Text] [Related]
18. Fatty acids-modified liposomes for encapsulation of bioactive peptides: Fabrication, characterization, storage stability and in vitro release.
Huang R; Song H; Wang X; Shen H; Li S; Guan X
Food Chem; 2024 May; 440():138139. PubMed ID: 38134830
[TBL] [Abstract][Full Text] [Related]
19. Controlled release application of multilamellar vesicles: a novel drug delivery approach.
Agnihotri SA; Soppimath KS; Betageri GV
Drug Deliv; 2010 Feb; 17(2):92-101. PubMed ID: 20067375
[TBL] [Abstract][Full Text] [Related]
20. Stability during in vitro digestion of lactoferrin-loaded liposomes prepared from milk fat globule membrane-derived phospholipids.
Liu W; Ye A; Liu W; Liu C; Singh H
J Dairy Sci; 2013 Apr; 96(4):2061-2070. PubMed ID: 23375971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
